NeuBase Therapeutics, Inc. received notice that Franklyn G. Prendergast, M.D., Ph.D., who served as a member of the Company?s Board of Directors since July 2019, passed away. Dr. Prendergast was also a member of the Audit Committee and Compensation Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | 0.00% | -48.93% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.93% | 1.39M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |